Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 509 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q1
DLA PIPER LLP (US) for ASSOCIATION FOR ADVANCING AUTOMATION
1st Quarter (Jan 1 - Mar 31) 2025 · Michigan · House · Senate · $40,000.00 income
Manufacturing
View →
Q1
DLA PIPER LLP (US) for XEROX HOLDINGS CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · Kentucky · House · Senate · $40,000.00 income
Pharmacy
View →
Q1
DLA PIPER LLP (US) for VERUS RESEARCH
1st Quarter (Jan 1 - Mar 31) 2025 · New Mexico · House · Senate · $50,000.00 income
Science/Technology
View →
Q1
DLA PIPER LLP (US) for PINDROP SECURITY, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Georgia · House · Senate · $150,000.00 income
Science/Technology
View →
Q1
DLA PIPER LLP (US) for BLUEHALO CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $150,000.00 income
Defense
View →
Q1
DLA PIPER LLP (US) for RESILIENT SOLUTIONS 21, INC. (RS21)
1st Quarter (Jan 1 - Mar 31) 2025 · New Mexico · House · Senate · $50,000.00 income
Defense, Energy/Nuclear
View →
Q1
DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Q1
DLA PIPER LLP (US) for GALT AEROSPACE AND AFFILIATES
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Defense
View →
Q1
DLA PIPER LLP (US) for ATLANTIC COAST CONFERENCE
1st Quarter (Jan 1 - Mar 31) 2025 · North Carolina · House · Senate · $120,000.00 income
Sports/Athletics
View →
Q1
DLA PIPER LLP (US) for CURRAX PHARMACEUTICALS LLC
1st Quarter (Jan 1 - Mar 31) 2025 · Tennessee · House · Senate · $60,000.00 income
Pharmacy
View →
Q1
DLA PIPER LLP (US) for AURA SUB, LLC
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $50,000.00 income
Consumer Issues/Safety/Products
View →
Q1
DLA PIPER LLP (US) for INDIVIOR INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
DLA PIPER LLP (US) for IRHYTHM TECHNOLOGIES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q1
DLA PIPER LLP (US) for THE NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Medicare/Medicaid, Health Issues, Budget/Appropriations
View →
Q1
DLA PIPER LLP (US) for AMERIHEALTH CARITAS
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $30,000.00 income
Medicare/Medicaid
View →
Q1
DLA PIPER LLP (US) for LAZARUS AI
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $60,000.00 income
Intelligence, Health Issues, Defense
View →
1T
DLA PIPER LLP (US) for INDEPENDENCE BLUE CROSS, LLC
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $40,000.00 income
Health Issues
View →
1TY
DLA PIPER LLP (US) for NEXUS PHARMACEUTICALS, LLC
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · $20,000.00 income
View →
Q1
DLA PIPER LLP (US) for DUKE UNIVERSITY HEALTH SYSTEM
1st Quarter (Jan 1 - Mar 31) 2025 · North Carolina · House · Senate · $20,000.00 income
Health Issues
View →
Q1Y
DLA PIPER LLP (US) for CROWDSTRIKE, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Texas
View →
Q1
DLA PIPER LLP (US) for BIOHAVEN PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Connecticut · House · Senate · $60,000.00 income
Health Issues
View →
Q1
DLA PIPER LLP (US) for RESEARCH SOCIETY ON ALCOHOL
1st Quarter (Jan 1 - Mar 31) 2025 · Tennessee · House · Senate · $20,000.00 income
Alcohol and Drug Abuse, Budget/Appropriations
View →
Q1
DLA PIPER LLP (US) for THE JED FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $20,000.00 income
Education, Health Issues
View →
Q1Y
DLA PIPER LLP (US) for IMMUNOCORE, LLC
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania
View →
Q1
DLA PIPER LLP (US) for INTRA-CELLULAR THERAPIES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $50,000.00 income
Health Issues
View →
Previous Page 19 of 21 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem